Cancer Cell Invasion
Cancer cells are highly susceptible to influences from their microenvironment.
We study tumor-microenvironment interactions to understand how cellular crosstalk enables tumor cell invasion.
Interested in liver metastases? Join us in the Stockholm Liver Metastases Research Network meetings, supported by Cancer Research KI since 2023.
We are a group of clinicians and scientists working with liver metastases in our clinical practice and in the laboratory. Current steering group:
Ernesto Sparrelid, Arne Östman, Marco Gerling, Jennie Engstrand, Carlos Fernández Moro, Pia Österlund
Publication in Nature Communication, 18th of August 2023
Sometimes, cancer cell invasion fails - and when this happens, the surrounding healthy tissue gets a chance to build a barrier around malignant tumors, leading to a much better prognosis for the patients, as we show in our new study published in Nature Communications.
We are part of the GUIDE.MRD consortium, funded by the EU
GUIDE.MRD is a consortium of leading academics, technology companies, pharmaceutical companies, and experts in multi-stakeholder engagements. Together, we aim to develop reference standards for circulating tumor DNA (ctDNA) diagnostics, clinically validate promising ctDNA diagnostics, and develop data to guide the use of multi-modal therapies with a non-invasive diagnostic test. Within GUIDE.MRD, our focus is on patients with colorectal cancer liver metastases and pancreatic cancer. Grateful to collaborate with Matthias Löhr and Jennie Engstrand and the GUIDE.MRD consortium!
Colorectal and Pancreatic Cancer
Colorectal and pancreatic cancers account for more than 5000 new cancer cases every year in Sweden alone.
The aggressiveness of both tumors is tightly controlled by their microenvironment, such that direct cell-cell interactions and stromal signaling processes regulate differentiation and proliferation of the tumor cells.
We use genetic mouse models, ex vivo cell culture with live cell 2-photon imaging, and single cell RNA sequencing to chart and to experimentally modify cell-cell interactions in these cancer types. We are building large clinical cohorts of liver metastases patients and pancreatic cancer patients at Karolinska University Hospital to validate our findings.
Our goal is to bridge clinical and basic research in order to uncover ways of exploiting cellular interactions for cancer therapy.
When tumor cells metastasise to distant organs, they encounter entirely new interaction partners.
Most metastases of gastrointestinal cancers are found in the liver, where tumor cells meet novel cell types, such as hepatocytes, hepatic stellate cells, liver sinusoid cells, and Kupffer cells.
Little is known about tumor-microenvironment interactions in metastases, despite their clinical importance. Therefore, we have developed models to alter the metastatic microenvironment in the liver, and we analyse clinical samples from patients with liver metastases. Our aim is to understand how cancer cells progress in the liver parenchyma, in order to find ways to slow down or even revert this process.
Who we are
- Marco Gerling, group leader & resident in oncology at Karolinska University Hospital, Tema Cancer.
- Natalie Geyer, postdoc, supported by The German Research Foundation
- Sara Söderqvist, PhD student
- Annika Viljamaa, Research Assistant
- Carlos Fernández Moro, consultant pathologist, postdoc, supported by SSMF
- Ann-Sophie Oppelt, Master student (KI), lab intern
- Caroline Salmén, affiliated (surgeon at Danderyd's hospital)
Affiliated PhD students
- Sólrún Kolbeinsdóttir (main supervisor Martin Enge)
- Laura Hermann, Master student from Vienna, Austria
- Sara Harrizi, Research Assistant
- Yousra Hamidi, Research Assistant
- Andrea del Valle, postdoc
- Iva Šutevski, visiting student. Iva did her Master's project in Molecular Biology with us and was visiting from the University of Zagreb, Croatia. She established an ex vivo model of liver metastases that can be imaged live with 2-photon confocal microscopy.
- Ewa Dzwonkowska, MSc; Ewa has completed an internship with us and finished her Master’s thesis on pancreatic cancer liver metastases in close collaboration with Martin Enge’s group at KI campus Solna.
- Rosan Heijboer, MSc: Rosan was a visiting student from Utrecht University in The Netherlands from March to December 2018 and set up a pancreas cancer metastases model in genetically modified mice.
- Anna Privitera, MSc: Anna joined as a visiting PhD student from Sicily from April to July 2019, working on bioinformatics analysis of stromal signaling modules in colorectal cancer.
- Xiaoze Li-Wang, senior lab manager
- Lorand Bozoky, medical student
- Linnéa Longhi, Biomedical Sciences student
- Sarah Rümpeler Calheiros Vera-Cruz, intern, Master student, University of Lübeck, Germany. Sarah worked on quantification and spatial remapping of tumor-hepatocyte interactions in pancreatic cancer liver metastases.
- Media Salmonsson Schaad, Research Assistant
- Manuela Cano, BMA student (main supervisor: Carlos Fernández Moro)
- Christos Vogiatzakis, summer student (stipend)
Main collaboration partners in Stockholm
An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver. Fernández Moro, Geyer, Harrizi, Hamidi et al. Nature Communications, https://doi.org/10.1038/s41467-023-40688-x
Analysis of the perimetastatic capsule that surround metastases with a particularly good prognosis.
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Latacz, Höppener, Bohlok et al., British Journal of Cancer, https://doi.org/10.1038/s41416-022-01859-7
Comprehensive clinicopathological guidelines for growth pattern scoring of liver metastases with a dash of novel hypothesis.
Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium. Bozóky, Fernández Moro et al., Neoplasia, December 2021, https://doi.org/10.1016/j.neo.2021.11.007
When pancreatic cancer cells invade into the small intestine, they change their phenotype and start to express markers of intestinal cells. Thanks to persistent efforts by the collaborating pathology team and their wealth of immunostainings, we could map this phenotypic switch demonstrating the remarkable plasticity of human pancreatic cancer cells in vivo.
An unsupervised method for physical cell interaction profiling of complex tissues. Nathanael Andrews, Jason T. Serviss et al. Nature Methods, 12th of July 2021. https://doi.org/10.1038/s41592-021-01196-2
Single cell sequencing generates detailed maps of cells in a given tissue. However, spatial information is lost. In CIM-seq, developed by Martin Enge's group at KI, we sequence multiplets of physically connected cells and deconvolute their composition based on single cell blueprints. The result is an atlas of tightly interacting cells.
We hope that this method will greatly help us understand the cellular crosstalk of invading cancer cells and their non-malignant neighbours.
- News & Views article by Daniel E Wagner (check out https://sammykatta.com/diversity as well).
- Nature Reviews Genetics research highlight.
Hedgehog Signaling in Colorectal Cancer: All in the Stroma?
Geyer N, Gerling M
Int J Mol Sci 2021 Jan;22(3):
Pathological features of vessel co-option versus sprouting angiogenesis.
Latacz E, Caspani E, Barnhill R, et al. Angiogenesis. 2020 Feb;23(1):43-54. doi: 10.1007/s10456-019-09690-0.
Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review.
Fernández Moro C, Bozóky B, Gerling M, BMJ Open Gastroenterol 2018 ;5(1):e000217
Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth.
Gerling M, Büller NV, Kirn LM, et al. Nature Communications 2016 08;7():12321
Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.
Blaas L, Pucci F, et al. Nature Cell Biology. 2016 Dec;18(12):1346-1356
Grateful for Support from
- The EU
- Svenska Sällskapet för Medicinsk Forskning (SSMF), Stora Anslag
- Cancer- och allergifonden
- Svenska Läkaresällskapet
- Åke Wiberg stiftelse
- Ruth och Richard Julins stiftelse
- Jeanssons stiftelse
- Karolinska Institutets fonder (to MG and NG)
- KID funding
- Cancer Research KI, Translational Seed Funding 2021, together with Ernesto Sparrelid
- The German Research Foundation, Walter Benjamin Program (to Natalie Geyer)
- Alex and Eva Wallströms Foundation (to Natalie Geyer)
- Svenska Sällskapet för Medicinsk Forskning (SSMF): Postdoc stipend to Carlos Fernández Moro